Skip to main content
SpringerLink
Log in

Exogenous Fungal Endophthalmitis

  • Chapter
  • First Online:
Endophthalmitis

  • 629 Accesses

Abstract

Exogenous fungal endophthalmitis is usually a consequence of keratitis, a penetrating injury to the globe, or eye surgery. Most cases are due to molds, especially Aspergillus species and Fusarium species. Candida species are much less likely than molds to cause exogenous endophthalmitis. Mold infections are more difficult to treat than Candida infections. Exogenous mold endophthalmitis usually requires therapy with intraocular antifungal agents, vitrectomy, and systemic antifungal agents. Voriconazole, given by intraocular injection and orally, has assumed an increasingly important role in treating exogenous fungal endophthalmitis. Voriconazole achieves excellent concentrations in the aqueous and vitreous, and most molds and Candida species are susceptible to this agent. In spite of the use of intraocular and systemic antifungal agents, outcomes for exogenous mold endophthalmitis are often poor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Vilela RC, Vilela L, Vilela P, et al. Etiological agents of fungal endophthalmitis: diagnosis and management. Int Ophthalmol. 2014;34:707–21.

    PubMed  Google Scholar 

  2. Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19:227–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Wykoff CC, Flynn Jr HW, Miller D, et al. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008;115:1501–7.

    Article  PubMed  Google Scholar 

  4. Chakrabarti A, Shivaprakash MR, Singh R, et al. Fungal endophthalmitis: fourteen years’ experience from a center in India. Retina. 2008;28:1400–7.

    Article  PubMed  Google Scholar 

  5. Henry CR, Flynn Jr HW, Miller D, Forster RK, Alfonso EC. Infectious keratitis progressing to endophthalmitis. A 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology. 2012;119:2443–9.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kunimoto DY, Das T, Shara S, et al. Microbiologic spectrum and susceptibility of isolates: part I: post-operative endophthalmitis. Am J Ophthalmol. 1999;128:240–2.

    Article  CAS  PubMed  Google Scholar 

  7. Kunimoto DY, Das T, Shara S, et al. Microbiologic spectrum and susceptibility of isolates: part II: posttraumatic endophthalmitis. Am J Ophthalmol. 1999;128:242–4.

    Article  CAS  PubMed  Google Scholar 

  8. Narang S, Gupta A, Gupta V, et al. Fungal endophthalmitis following cataract surgery: clinical presentation, microbiological spectrum, and outcome. Am J Ophthalmol. 2001;132:609–17.

    Article  CAS  PubMed  Google Scholar 

  9. Merchant A, Zacks CM, Wilhelmus K, et al. Candidal endophthalmitis after keratoplasty. Cornea. 2001;20:226–9.

    Article  CAS  PubMed  Google Scholar 

  10. Tappeiner C, Goldblum D, Zimmerli S, et al. Donor-to-host transmission of Candida glabrata to both recipients of corneal transplants from the same donor. Cornea. 2009;28:228–30.

    Article  PubMed  Google Scholar 

  11. Schotveld JH, Raijmakers AJ, Henry Y, Zaal MJ. Donor-to-host transmitted Candida endophthalmitis after penetrating keratoplasty. Cornea. 2005;24:887–9.

    Article  PubMed  Google Scholar 

  12. Roy M, Park BK, Chiller TM. Donor-derived fungal infections in transplant patients. Curr Fungal Infect Rep. 2010;4:219–28.

    Article  Google Scholar 

  13. McCray E, Rampell N, Solomon SLO, et al. Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation. J Clin Microbiol. 1986;24:625–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Stern WH, Tamura E, Jacobs RA, et al. Epidemic postsurgical Candida parapsilosis endophthalmitis. Ophthalmology. 1985;92:1701–9.

    Article  CAS  PubMed  Google Scholar 

  15. Kauffman CA, Bradley SF, Vine AK. Candida endophthalmitis associated with intraocular lens implantation: efficacy of fluconazole therapy. Mycoses. 1993;36:13–7.

    Article  CAS  PubMed  Google Scholar 

  16. Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Microbiol Rev. 2000;13:662–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wong VKW, Tasman W, Eagle RC, Rodriquez A. Bilateral Candida parapsilosis endophthalmitis. Arch Ophthalmol. 1997;115:670–2.

    Article  CAS  PubMed  Google Scholar 

  18. Weng CY, Parke III DW, Walter SD, et al. Candida glabrata endophthalmitis transmitted from graft to host after Descemet stripping automated endothelial keratoplasty. JAMA Ophthalmol. 2014;132:1381–3.

    Article  PubMed  Google Scholar 

  19. Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev. 2003;16:730–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Sharma S, Kunimoto DY, Gopinathan U, et al. Evaluation of corneal scraping smear examination methods in the diagnosis of bacterial and fungal keratitis: a survey of eight years of laboratory experience. Cornea. 2002;21:643–7.

    Article  PubMed  Google Scholar 

  21. Tarai B, Gupta A, Ray P, Shivaprakash MR, Chakrabarti A. Polymerase chain reaction for early diagnosis of post-operative fungal endophthalmitis. Indian J Med Res. 2006;123:671–8.

    CAS  PubMed  Google Scholar 

  22. Hidalgo JA, Alangaden GJ, Dean E, et al. Fungal endophthalmitis diagnosis by detection of Candida albicans DNA in intraocular fluid by use of a species-specific polymerase chain reaction. J Infect Dis. 2000;181:1198–201.

    Article  CAS  PubMed  Google Scholar 

  23. Jaeger EE, Carroll NM, Choudhury S, et al. Rapid detection and identification of Candida, Aspergillus, and Fusarium species in ocular samples using nested PCR. J Clin Microbiol. 2000;38:2902–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Kuriakose T, Kothari M, Paul P, et al. Intracameral amphotericin B injection in the management of deep keratomycosis. Cornea. 2002;21:653–6.

    Article  PubMed  Google Scholar 

  25. Yoon KC, Jeong IY, Im SK, et al. Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis. Cornea. 2007;26:814–8.

    Article  PubMed  Google Scholar 

  26. Yilmaz S, Ture M, Maden A. Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis. Cornea. 2007;26:398–402.

    Article  PubMed  Google Scholar 

  27. Shen YC, Wang CY, Tsai HY, Lee HN. Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis. Am J Ophthalmol. 2010;149:916–21.

    Article  CAS  PubMed  Google Scholar 

  28. Shen YC, Wang MY, Wang CY, et al. Pharmacokinetics of intracameral voriconazole injection. Antimicrob Agents Chemother. 2009;53:2156–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lin RC, Sanduja N, Hariprasad SM. Successful treatment of postoperative fungal endophthalmitis using intravitreal and intracameral voriconazole. J Ocul Pharmacol Ther. 2008;24:245–8.

    Article  CAS  PubMed  Google Scholar 

  30. Vemulakonda GA, Hariprasad SM, Mieler WF, et al. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmol. 2008;126:18–22.

    Article  CAS  PubMed  Google Scholar 

  31. Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother. 2007;51:239–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Al-Badriyeh D, Leung L, Roydhouse T, et al. Prospective open-label study of the administration of two-percent voriconazole eye drops. Antimicrob Agents Chemother. 2009;53:3153–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lau D, Fedinands M, Leung L, et al. Penetration of voriconazole, 1% eye drops into human aqueous humor: a prospective open-label study. Arch Ophthalmol. 2008;126:343–6.

    Article  CAS  PubMed  Google Scholar 

  34. Riddell IV J, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis. 2011;52:648–53.

    Article  CAS  PubMed  Google Scholar 

  35. Hariprasad SM, Mieler WF, Holz ER, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004;122:42–7.

    Article  CAS  PubMed  Google Scholar 

  36. Pfaller MA, Andes D, Arendrup MC, et al. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis. 2011;70:330–43.

    Article  CAS  PubMed  Google Scholar 

  37. Malani AN, Kerr LE, Kauffman CA. Voriconazole: how to use this antifungal agent and what to expect. Sem Respir Crit Care Medicine. 2015;36(5):786–95.

    Article  Google Scholar 

  38. Zhang YQ, Wang WJ. Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina. 2005;25:746–50.

    Article  PubMed  Google Scholar 

  39. Shukla PK, Kumar M, Keshava GBS. Mycotic keratitis: an overview of diagnosis and therapy. Mycoses. 2008;51:183–99.

    Article  CAS  PubMed  Google Scholar 

  40. Dursun D, Fernandez V, Miller D, Alfonso EC. Advanced Fusarium keratitis progressing to endophthalmitis. Cornea. 2003;22:300–3.

    Article  PubMed  Google Scholar 

  41. Benz MS, Scott IU, Flynn Jr HW, et al. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol. 2004;137:38–42.

    Article  PubMed  Google Scholar 

  42. Chang DC, Grant GB, O’Donnell K, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296:953–63.

    Article  CAS  PubMed  Google Scholar 

  43. Khor W-B, Aung T, Saw S-M, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA. 2006;295:2867–73.

    Article  CAS  PubMed  Google Scholar 

  44. Alfonso EC, Cantu-Dibildox J, Munir WM, et al. Insurgence of Fusarium keratitis associated with contact lens wear. Arch Ophthalmol. 2006;124:941–7.

    Article  PubMed  Google Scholar 

  45. Bernal MD, Acharya NR, Lietman TM, et al. Outbreak of Fusarium keratitis in soft contact lens wearers in San Francisco. Arch Ophthalmol. 2006;124:1051–3.

    Article  PubMed  Google Scholar 

  46. Bullock JD, Warwar RE, Elder L, Northern WI. Temperature instability of ReNu with MoistureLoc. Arch Ophthalmol. 2008;126:1493–8.

    Article  PubMed  Google Scholar 

  47. Cornut PL, Thuret G, Creuzot-Garcher C, et al. Relationship between baseline clinical data and microbiologic spectrum in 100 patients with acute postcataract endophthalmitis. Retina. 2012;32:549–57.

    Article  PubMed  Google Scholar 

  48. Tabbara KF, Jabarti A. Hospital construction-associated outbreak of ocular aspergillosis after cataract surgery. Ophthalmology. 1998;105:522–6.

    Article  CAS  PubMed  Google Scholar 

  49. Gungel H, Eren MH, Pinarci ERY, et al. An outbreak of Fusarium solani endophthalmitis after cataract surgery in an eye training and research hospital in Istanbul. Mycoses. 2011;54:e767–74.

    Article  PubMed  Google Scholar 

  50. Mikosz CA, Smith RM, Kim M, et al. Fungal endophthalmitis associated with compounded products. Emerg Infect Dis. 2014;20:248–56.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Sheyman AT, Cohen BZ, Friedman AH, et al. An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone. JAMA Ophthalmol. 2013;131:864–9.

    Article  CAS  PubMed  Google Scholar 

  52. Durand ML, Kim IK, D’Amico DJ, et al. Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. Am J Ophthalmol. 2005;140:552–4.

    Article  CAS  PubMed  Google Scholar 

  53. Miceli MH, Kauffman CA. Isavuconazole: a new broad-spectrum triazole antifungal agent. Clin Infect Dis. 2015;61(10):1558–65.

    Article  PubMed  Google Scholar 

  54. Troke P, Obenga G, Gaujoux T, et al. The efficacy of voriconazole in 24 ocular Fusarium infections. Infection. 2013;41:15–20.

    Article  CAS  PubMed  Google Scholar 

  55. Klont RR, Eggink CA, Rijs AJMM, Wesseling P, Verweij PE. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole. Clin Infect Dis. 2005;40:e110–2.

    Article  PubMed  Google Scholar 

  56. Spadea L, Abbouda A, Abicca I, Paroli MP. Aspergillus flavus endophthalmitis after penetrating keratoplasty combined with cataract phacoemulsification and IOL implantation. Int Ophthalmol. 2015;35:145–8.

    Article  PubMed  Google Scholar 

  57. Yildiz BK, Hasanreisoglu M, Aktas Z, et al. Fungal keratitis secondary to Scedosporium apiospermum infection and successful treatment with surgical and medical intervention. Int Ophthalmol. 2014;34:305–8.

    Article  Google Scholar 

  58. Nochez Y, Arsene S, Le Guellec C, et al. Unusual pharmacokinetics of intravitreal and systemic voriconazole in a patient with Scedosporium apiospermum endophthalmitis. J Ocul Pharmacol Ther. 2008;24:87–90.

    Article  CAS  PubMed  Google Scholar 

  59. Aydin S, Ertugrul B, Gultekin B, Uyar G, Kir E. Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy. BMC Infect Dis. 2007;7:87–91.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Figueroa MS, Fortun J, Clement A, De Arévalo BF. Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole. Retina. 2004;24:319–20.

    Article  PubMed  Google Scholar 

  61. Garbino J, Ondrusova A, Baglivo E, et al. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis. 2002;34:701–3.

    Article  PubMed  Google Scholar 

  62. Belenitsky MP, Liu C, Tsui I. Scedosporium apiospermum endophthalmitis treated early with intravitreous voriconazole results in recovery of vision. J Ophthalmic Inflamm Infect. 2012;2:157–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Sen P, Gopal L, Sen PR. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series. Retina. 2006;26:935–9.

    Article  PubMed  Google Scholar 

  64. Pascual A, Calandra T, Bolay S, et al. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008;46:201–11.

    Article  CAS  PubMed  Google Scholar 

  65. Sponsel WE, Graybill JR, Nevarez HL, Dang D. Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis. Br J Ophthalmol. 2002;86:829–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Tu EY, McCartney DL, Beatty RF, et al. Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592). Am J Ophthalmol. 2007;143:222–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, 2215 Fuller Road, Ann Arbor, MI, 48105, USA

    Carol A. Kauffman MD

Authors
  1. Carol A. Kauffman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carol A. Kauffman MD .

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Marlene L. Durand

  2. Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA

    Joan W. Miller

  3. Massachusetts Eye and Ear, Harvard Medical School, BOSTON, Massachusetts, USA

    Lucy H. Young

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kauffman, C.A. (2016). Exogenous Fungal Endophthalmitis. In: Durand, M., Miller, J., Young, L. (eds) Endophthalmitis. Springer, Cham. https://doi.org/10.1007/978-3-319-29231-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29231-1_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29229-8

  • Online ISBN: 978-3-319-29231-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation